Rare Combination of Adverse Effects Associated With Lamotrigine Treatment

    January 2018 in “ Journal of Neurology Research
    Mustafa Ceylan, Onur Ceylan
    Image
    Studysummary This case report describes a 23-year-old male who developed leukopenia, thrombocytopenia, and rash associated with lamotrigine treatment, emphasizing the importance for clinicians to monitor for serious side effects, especially early in treatment. Our plain-language summary of this paper — not a Tressless recommendation.
    The document from 2018 discussed a case of a 23-year-old male who experienced rare adverse effects from Lamotrigine (LTG) treatment, an antiepileptic drug used for epilepsy. The patient developed leukopenia, thrombocytopenia, and a skin rash. These serious side effects, although rare, are of clinical importance and often lead to drug withdrawal. The document emphasized that clinicians should be aware of these potential serious side effects, especially at the beginning of the treatment, in addition to other less significant complaints such as nausea, dizziness, and malaise.
    Discuss this study in the Community →